Navigation Links
MD Anderson honors 2 champions for women in medicine and research
Date:3/13/2014

HOUSTON -- Two champions of gender equality in medicine and research will be honored by The University of Texas MD Anderson Cancer Center at 4 p.m., today in MD Anderson's Onstead Auditorium.

Laurie Glimcher, M.D., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College and provost for medical affairs of Cornell University since 2012, will receive the 2014 Margaret L. Kripke Legend Award. She will speak about endoplasmic reticulum stressors in disease.

Thomas Burke, M.D., executive vice president of MD Anderson Cancer Network, will be honored with the President's Leadership Award for Advancing Women Faculty. His remarks will address gender inclusiveness.

Glimcher is noted immunologist, advocate

Glimcher joined Weill Cornell from Harvard, where she was one of the first women professors awarded tenure. She is a renowned immunologist. Her primary research interests are molecular pathways that regulate CD4T helper cell development and activation, work that has led to important advancements in understanding immune function.

As president of the American Association of Immunologists, she founded the Primary Caregivers Technical Assistance Programs, known as the Glimcher Initiative, at the National Institutes of Health (NIH). The program, which she also helped establish at Harvard, supports postdoctoral women scientists with child care responsibilities by providing additional funds for laboratory assistance. Under Glimcher's leadership, Weill Cornell opened an on-site child care center last year.

"I am thrilled and deeply humbled to be the 2014 recipient of the Margaret L. Kripke Legend Award," Glimcher said. "I've dedicated my career to supporting and recognizing women physicians and scientists so they can not only succeed, but go farther than they ever thought they could. I'm proud of the progress we've made in nurturing women leaders in the biomedical sciences and excited for what we can accomplish in the future."

The Kripke Award recognizes a person who has made significant contributions to the advancement and promotion of women in cancer medicine and cancer science. It was established in 2008 by Women Faculty Programs to honor Professor Emerita Margaret L. Kripke, Ph.D., for her unwavering advocacy for and promotion of women in academic medicine and science.

The award is supported by The Vivian L. Smith Foundation, the estate of Elizabeth P. Scott and Polo on the Prairie, a U.S. Polo Association-sanctioned event, on a pasture-turned-polo-field in West Texas, that's one of MD Anderson's longest-running and most popular annual fundraising events.

Kripke, a distinguished scientist, achieved many firsts for women at MD Anderson, culminating in her promotion to executive vice president and chief academic officer. She recently was appointed chief scientific officer of the Cancer Prevention and Research Institute of Texas.

"This is the second year in a row the Kripke Legend Award is being made to a woman who is dean of a major U.S. medical school," said Elizabeth Travis, Ph.D., MD Anderson associate vice president of Women Faculty Programs. "Laurie Glimcher is one of the 23 women who have reached the highest level of leadership in academic medicine. She is an outstanding cancer medicine researcher and teacher, as well as a longstanding advocate of women, and we are thrilled to have her as the awardee."

Burke works to ensure equal opportunities

Burke joined the faculty of MD Anderson in 1988 and was appointed professor in 1998. In 2007, he was named executive vice president and physician-in-chief, an appointment he held through 2013 when he was named executive vice president, MD Anderson Cancer Network.

As the physician in charge of clinical operations, Burke used his position to identify and promote women faculty to medical director positions. He has mentored many woman faculty, created opportunities and helped prepare women for leadership positions through special assignments.

Burke is a practicing gynecologic oncology surgeon whose clinical and research work focuses on vulvar and endometrial cancers.

"I have benefited from the wisdom and guidance of many wonderful mentors throughout my education and career," Burke said. "Several of them were talented women. I am thrilled to be recognized for fostering the professional development of friends and colleagues over the past 25 years at MD Anderson."

The President's Leadership Award for Advancing Women Faculty was initiated last year to recognize the contributions of an MD Anderson faculty member who has had a significant impact on the career advancement of women faculty. Recipients provide vision and leadership to address practices that inadvertently disadvantage women faculty and serve as change agents by creating an environment where women can flourish and advance to leadership positions.

"I am delighted to honor and recognize two individuals who advocate above and beyond the expected for the career advancement of women faculty," said Ronald DePinho, M.D, president of MD Anderson. "Recipients of both awards are chosen based on demonstrating, through their words and actions, a deep personal and professional commitment to this value."


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Related medicine news :

1. UT MD Anderson study finds cancer related pain often undertreated
2. University of Houston Graduate College of Social Work announces partnership with MD Anderson
3. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
4. UT MD Anderson study finds link between depressive symptoms and cancer survival
5. UT MD Anderson Cancer Center launches unprecedented Moon Shots Program
6. UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer
7. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
8. UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy
9. UT MD Anderson scientists find protein that reins in runaway network
10. MD Anderson study finds qigong improves quality of life for breast cancer patients
11. Leading National Law Firm Anderson Kill & Olick Concludes NRRA Not Intended to Apply to Captive Insurance Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: